CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Simon Barry J. Director | Sale 10b5-1 | −25,000 | $10.75 | $269K | 2,777,788 |
| 2026-10-02 | Cohen Cheryl Director | Option exercise 10b5-1 | +55,979 | $2.98 | $167K | 181,365 |
| 2026-10-02 | Cohen Cheryl Director | Sale 10b5-1 | −81,056 | $10.50 | $851K | 100,309 |
| 2026-10-02 | Cohen Cheryl Director | Option exercise · Stock Option (right to buy) 10b5-1 | −55,979 | 55,979 | ||
| 2026-07-02 | Cohen Cheryl Director | Option exercise 10b5-1 | +55,979 | $2.98 | $167K | 256,596 |
| 2026-07-02 | Cohen Cheryl Director | Sale 10b5-1 | −131,210 | $9.50 | $1.2M | 125,386 |
| 2026-07-02 | Cohen Cheryl Director | Option exercise · Stock Option (right to buy) 10b5-1 | −55,979 | 111,958 | ||
| 2026-07-01 | Selecky Christobel Director | Option exercise 10b5-1 | +35,064 | $2.98 | $104K | 35,064 |
| 2026-07-01 | Selecky Christobel Director | Option exercise 10b5-1 | +124,414 | $2.99 | $372K | 159,478 |
| 2026-07-01 | Selecky Christobel Director | Sale 10b5-1 | −159,478 | $9.02 | $1.4M | 0 |
| 2026-07-01 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −35,064 | 0 | ||
| 2026-07-01 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −124,414 | 0 | ||
| 2026-06-30 | Selecky Christobel Director | Option exercise 10b5-1 | +700 | $2.98 | $2K | 700 |
| 2026-06-30 | Selecky Christobel Director | Option exercise 10b5-1 | +300 | $2.99 | $897 | 1,000 |
| 2026-06-30 | Selecky Christobel Director | Sale 10b5-1 | −1,000 | $9.00 | $9K | 0 |
| 2026-06-30 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −700 | 35,064 | ||
| 2026-06-30 | Selecky Christobel Director | Option exercise · Stock Option (right to buy) 10b5-1 | −300 | 124,414 | ||
| 2026-06-29 | Selecky Christobel Director | Option exercise 10b5-1 | +32,173 | $2.98 | $96K | 32,173 |
| 2026-06-29 | Selecky Christobel Director | Option exercise 10b5-1 | +33,549 | $2.99 | $100K | 65,722 |
| 2026-06-29 | Selecky Christobel Director | Option exercise 10b5-1 | +30,000 | $2.84 | $85K | 95,722 |
Page 1 of 12 · 226 trades